Multifaceted role of PRDM proteins in human cancer

A Casamassimi, M Rienzo, E Di Zazzo… - International Journal of …, 2020 - mdpi.com
The PR/SET domain family (PRDM) comprise a family of genes whose protein products
share a conserved N-terminal PR [PRDI-BF1 (positive regulatory domain I-binding factor 1) …

Handling of allergen immunotherapy in the COVID‐19 pandemic: an ARIA‐EAACI statement

L Klimek, M Jutel, C Akdis, J Bousquet, M Akdis… - Allergy, 2020 - Wiley Online Library
The current COVID-19 pandemic influences many areas of social life, medical treatments
and the way allergy diagnosis and treatment is performed. Allergen-specific immunotherapy …

Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c

L Klimek, O Pfaar, M Worm, KC Bergmann, T Bieber… - Allergo Journal, 2020 - Springer
Allergenimmuntherapie, Covid-19, SCIT, SLIT, anti virale Immunität aÜbersetzte und
inhaltlich auf die Situation in Deutschland, Österreich und der Schweiz adaptierte Fassung …

[HTML][HTML] Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA …

L Klimek, O Pfaar, M Worm, KC Bergmann… - Allergologie …, 2020 - ncbi.nlm.nih.gov
Allergen-specific immunotherapy (AIT) is the only causal therapy with a proven long-term
benefit in allergic airway diseases, such as allergic bronchial asthma or allergic …

Performance of different diagnostic PD-L1 clones in head and neck squamous cell carcinoma

J Ribbat-Idel, FF Dressler, R Krupar… - Frontiers in …, 2021 - frontiersin.org
Background: The approval of immune checkpoint inhibitors in combination with specific
diagnostic biomarkers presents new challenges to pathologists as tumor tissue needs to be …

EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo−/radioresistance in nasopharyngeal carcinoma

Y Lu, Y Liang, X Zheng, X Deng, W Huang… - Journal of Experimental & …, 2019 - Springer
Background Aberrant EVI1 expression is frequently reported in cancer studies; however, its
role in nasopharyngeal carcinoma (NPC) has not been examined in detail. The aim of the …

[HTML][HTML] COVID-19 vaccination and allergen immunotherapy (AIT)–A position paper of the German Society for Applied Allergology (AeDA) and the German Society for …

L Klimek, O Pfaar, E Hamelmann… - Allergologie …, 2021 - ncbi.nlm.nih.gov
Background: Vaccinations against severe acute respiratory syndrome coronavirus type 2
(SARS-CoV-2) are intended to induce an immune response to protect against …

EVI1 in leukemia and solid tumors

B Liang, J Wang - Cancers, 2020 - mdpi.com
Simple Summary Ecotropic viral integration site 1 (EVI1) is transcriptionally activated in a
subset of myeloid leukemias. Since its discovery, other isoforms of EVI1 have been …

EVI1 induces autophagy to promote drug resistance via regulation of ATG7 expression in leukemia cells

Y Niu, X Yang, Y Chen, X Jin, L Li, Y Guo, X Li… - …, 2020 - academic.oup.com
Ecotropic viral integration site 1 (EVI1) is an oncogenic transcription factor, which is
abnormally expressed in myeloid leukemia and other several solid cancers. It is associated …

Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma

SG Hakim, C Taubitz, S Hoppe, D Steller… - Frontiers in …, 2023 - frontiersin.org
The epithelial-mesenchymal transition (EMT) is a biological mechanism in multiple
pathophysiological diseases. Related alterations in cadherin expression play a crucial role …